| Literature DB >> 32784986 |
Petra Chocholata1, Vlastimil Kulda1, Jana Dvorakova1, Jana Kolaja Dobra1, Vaclav Babuska1.
Abstract
This study aimed to develop polyvinyl alcohol (PVA) -based scaffold enriched with hyaluronic acid (HA) and hydroxyapatite (HAp) using physical crosslinking by freezing-thawing method. We accomplished biological evaluation of scaffolds, swelling degree, bioactivity assessment, and hemolytic test. The results showed that all types of scaffolds should be safe for use in the human body. The culturing of human osteoblast-like cells MG-63 and their proliferation showed better adhesion of cells due to the presence of HA and confirmed better proliferation depending on the amount of HAp. This paper gives the optimal composition of the scaffold and the optimal amount of the particular components of the scaffold. Based on our results we concluded that the best PVA/HA/HAp combination is in the ratio 3:1:2.Entities:
Keywords: biological evaluation; bone tissue engineering; hyaluronic acid; hydroxyapatite; polyvinyl alcohol; scaffold
Mesh:
Substances:
Year: 2020 PMID: 32784986 PMCID: PMC7461130 DOI: 10.3390/ijms21165719
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Results of swelling degree, bioactivity assessment, and the test of hemocompatibility.
| Sample | Composition Ratio [PVA/HA/HAp] | Swelling Degree [%] | Bioactivity Assessment [%] | Hemolysis [%] 1 |
|---|---|---|---|---|
| A | 3:1:0 | 902.06 | 110.55 | 0.97 (+++) |
| B | 1:1:0 | 999.61 | 118.70 | 0.68 (+++) |
| HA1 | 3:1:1 | 917.23 | 102.50 | 0.39 (+++) |
| HA2 | 3:1:2 | 804.27 | 97.25 | 1.46 (+++) |
| HA3 | 3:1:3 | 770.82 | 113.30 | 1.55 (+++) |
| HB1 | 1:1:1 | 1020.45 | 124.80 | 0.10 (+++) |
| HB2 | 1:1:2 | 797.92 | 122.70 | 0.58 (+++) |
| HB3 | 1:1:3 | 404.79 | 102.70 | 1.46 (+++) |
1 Values of hemolysis < 5% mean high hemocompatibility (+++) of material [19].
Figure 1Timeline of adhesion and proliferation monitoring. CCK-8 is Cell Counting Kit-8.
Figure 2Graphical representation of cell viability (adhesion—day 1, proliferation—day 7, 14, and 21). (a) Samples A, HA1, HA2, and HA3 and (b) samples B, HB1, HB2, and HB3. Error bars represent ±SD. A: PVA/HA = 3:1; HA1: PVA/HA/Hap = 3:1:1; HA2: PVA/HA/Hap = 3:1:2; HA3: PVA/HA/Hap = 3:1:3; B: PVA/HA = 1:1; HB1: PVA/HA/Hap = 1:1:1; HB2: PVA/HA/Hap = 1:1:2; HB3: PVA/HA/Hap = 1:1:3.
Figure 3Visual comparison of MG-63 cell colonies stained with hematoxylin and eosin. (a) Sample A, (b) sample B, (c) sample HA1, (d) sample HA2, (e) sample HA3, (f) sample HB1, (g) sample HB2, (h) sample HB3. A: PVA/HA = 3:1; HA1: PVA/HA/Hap = 3:1:1; HA2: PVA/HA/Hap = 3:1:2; HA3: PVA/HA/Hap = 3:1:3; B: PVA/HA = 1:1; HB1: PVA/HA/Hap = 1:1:1; HB2: PVA/HA/Hap = 1:1:2; HB3: PVA/HA/Hap = 1:1:3. Scale bar = 50 µm.
Order, amount, and formula of reagents for preparing 500 mL of SBF.
| Order | Reagent | Amount |
|---|---|---|
| 1 | NaCl | 4.018 g |
| 2 | NaHCO3 | 0.178 g |
| 3 | KCl | 0.114 g |
| 4 | K2HPO4 3H2O | 0.116 g |
| 5 | MgCl2 6H2O | 0.159 g |
| 6 | 1M HCl | 19.5 mL |
| 7 | CaCl2 | 0.146 g |
| 8 | Na2SO4 | 0.036 g |
| 9 | Tris | 3.059 g |
| 10 | 1M HCl | 1.84 mL |